The statements below are read from ARISTO BIO T AND LIFESC L’s filed results, 6 filed quarters and 11 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: H2 FY25-26 · filed Jul 18, 2026 · audited
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | H2 FY23Mar 2023 | H1 FY24Sep 2023 | H1 FY25Sep 2024 | H2 FY25Mar 2025 | H1 FY26Sep 2025 | H2 FY26Mar 2026Latest | YoYlatest |
|---|---|---|---|---|---|---|---|
| Sales | 88.8 | 133 | 214 | 104 | 256 | 107 | +3.2% |
| 85.2 | 128 | 206 | 103 | 249 | 99.1 | -3.6% | |
| Operating profit | 3.64 | 5.24 | 8.15 | 1.12 | 7.90 | 8.15 | n/m |
| OPM % | 4.1% | 3.9% | 3.8% | 1.1% | 3.1% | 7.6% | +6.5 pp |
| Other income | 0.30 | 0.13 | 0.23 | 0.23 | 0.09 | 0.37 | +62.2% |
| Interest | 1.98 | 1.02 | 1.02 | 0.64 | 0.98 | 2.91 | n/m |
| Depreciation | 0.82 | 0.78 | 1.29 | 1.32 | 1.47 | 1.46 | +10.8% |
| Profit before tax | 1.14 | 3.58 | 6.07 | -0.60 | 5.54 | 4.15 | n/m |
| Tax % | 12.5% | 28.2% | 25.0% | n/a (loss) | 24.8% | 27.5% | — |
| Net profit | 1.00 | 2.57 | 4.55 | -0.49 | 4.17 | 3.01 | n/m |
| EPS (₹) | 1.78 | 3.78 | 6.69 | -0.72 | 6.12 | 4.43 | n/m |
No results filing with a recorded time yet — reactions appear from the first quarter whose announcement we timestamped (May 2026 onward), on the session the market could trade it.
